Hector Keun

18PUBLICATIONS
113CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Dec 19, 2025
RAS/PI3K pathway mutations sensitise epithelial ovarian cancer cells to a PARP/NAMPT inhibitor combination.

Michael Gruet, Yitao Xu, Lyutong An

|Jan 14, 2025
Multi-omics architecture of childhood obesity and metabolic dysfunction uncovers biological pathways and prenatal determinants.

Nikos Stratakis, Augusto Anguita-Ruiz, Lorenzo Fabbri

|Aug 26, 2024
PTEN Loss Shapes Macrophage Dynamics in High-Grade Serous Ovarian Carcinoma.

Sarah Spear, Olivia Le Saux, Hasan B Mirza

|Apr 05, 2024
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study.

David J Pinato, Antonio D'Alessio, Claudia Angela Maria Fulgenzi

|Jan 18, 2023
A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer.

Sarah Halford, Gareth J Veal, Stephen R Wedge

Pageof 3